Factor VII Matched ELISA Antibody Pair Set,Mouse

Cat: SEK50034
Contact us:
215-583-7898
order@sinobiological.com
Distributors
All Factor VII Reagents
CRO Services
Product recommended

All Factor VII Reagents
Factor VII Matched ELISA Antibody Pair Set,Mouse General Information
Product name
Factor VII Matched ELISA Antibody Pair Set,Mouse
Assay type
Solid Phase Sandwich ELISA
Specificity
Quantitative determination of Mouse Factor VII
Assay range
23.44-1500
Materials provided
1. Capture Antibody 0.3 mg/mL of rabbit anti-mouse FⅦ monoclonal antibody, Dilute to a working concentration of 2 μg/mL in CBS before coating. (Catalog: # 50034-R003)
2. Detection Antibody 0.5 mg/mL rabbit anti-mouse FⅦ monoclonal antibody conjugated to horseradish-peroxidase (HRP). Dilute to working concentration of 0.25 μg/mL in detection antibody dilution buffer before use. (Catalog: # 50034-R121)
3. Standard Each vial contains 90 ng of recombinant mouse FⅦ. Reconstitute with 1 mL detection antibody dilution buffer. After reconstitution, store at -20℃ to -80℃ in a manual defrost freezer. A seven-point standard curve usi ng 2-fold serial dilutions in sample dilution buffer, and a high standard of 1.5 ng/mL is recommended.
Product overview
This Factor VII Matched ELISA Antibody Pair Set,Mouse is a solid phase sandwich ELISA for quantitative determination of Mouse Factor VII . It contains Mouse Factor VII capture antibody, Mouse Factor VII detector antibody (HRP) and a highly purified CHO Stable-expressed recombinant Mouse Factor VII protein. This Pair Set is at affordable price for researchers.
Shipping
This Matched ELISA Antibody Pair Set is shipped at ambient temperature.
Storage
Capture Antibody: Aliquot and store at -20℃ to -80℃ for up to 6 months from date of receipt. Avoid repeated freeze-thaw cycles.
Detection Antibody: Protect it from prolonged exposure to light. Aliquot and store at -20℃ to -80℃ and for up to 6 months from date of receipt. Avoid repeated freeze-thaw cycles.
Standard: Store lyophilized standard at -20℃ to -80℃ for up to 6 months from date of receipt. Aliquot and store the reconstituted Standard at -80℃ for up to 1 month. Avoid repeated freeze-thaw cycles.
Factor VII Matched ELISA Antibody Pair Set,Mouse Images
Mouse Coagulation Factor VII ELISA Pair Set Standard Curve 13976
Factor VII Matched ELISA Antibody Pair Set,Mouse Alternative Names
AI132620 Matched ELISA Antibody Pair Set, Mouse;Cf7 Matched ELISA Antibody Pair Set, Mouse;FVII Matched ELISA Antibody Pair Set, Mouse
Factor VII Background Information

Coagulation factor VII, also known as Serum prothrombin conversion accelerator, Factor VII, F7 and FVII, is a member of the peptidase S1 family. Factor VII is one of the central proteins in the coagulation cascade. It is an enzyme of the serine protease class, and Factor VII (FVII) deficiency is the most frequent among rare congenital bleeding disorders. Factor VII contains two EGF-like domains, one Gla (gamma-carboxy-glutamate) domain and one peptidase S1 domain. The main role of factor VII is to initiate the process of coagulation in conjunction with tissue factor (TF). Tissue factor is found on the outside of blood vessels, normally not exposed to the blood stream. The action of the Factor VII is impeded by tissue factor pathway inhibitor (TFPI), which is released almost immediately after initiation of coagulation. Factor VII is vitamin K dependent and is produced in the liver. Upon vessel injury, tissue factor is exposed to the blood and circulating Factor VII. Once bound to TF, FVII is activated to FVIIa by different proteases, among which are thrombin (factor IIa), factor Xa, IXa, XIIa, and the FVIIa-TF complex itself. Recombinant activated factor VII (rFVIIa) is a haemostatic agent, which was originally developed for the treatment of haemophilia patients with inhibitors against factor FVIII or FIX. FVIIa binds specifically to endothelial protein C receptor (EPCR), a known cellular receptor for protein C and activated protein C, on the endothelium. rFVIIa is a novel hemostatic agent, originally developed for the treatment of hemorrhage in hemophiliacs with inhibitors, which has been successfully used recently in an increasing number of nonhemophilic bleeding conditions.

Full Name
coagulation factor VII (serum prothrombin conversion accelerator)
References
  • Franchini M, et al. (2007) Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Blood Coagul Fibrinolysis. 18(7): 589-93.
  • Lapecorella M, et al. (2008) Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia. 14(6): 1170-5.
  • Grottke O, et al. (2010) Activated recombinant factor VII (rFVIIa). Best Pract Res Clin Anaesthesiol. 24(1): 95-106.
  • Product Description Assay Range (pg/ml) Sample Type Catalog# (PDF)
    Factor VII ELISA Kit, Mouse Serum KIT50034
    info info
    添加购物车成功! 添加购物车失败!